Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations
April 10, 2024
April 10, 2024
BOSTON, Massachusetts, April 10 -- The U.S. Department of Justice Drug Enforcement Administration's New England Division issued the following news release:
NEWARK, N.J. - A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today
The manufacturer, Novel Laboratories Inc. (Nov . . .
NEWARK, N.J. - A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today
The manufacturer, Novel Laboratories Inc. (Nov . . .